COVID-19 and the nervous system

por Berger, Joseph R.
Publicado 2020

Learning More About HHV-6 Encephalitis

por Berger, Joseph R.
Publicado 2021

Improving risk‐stratification of natalizumab‐associated PML

por Tugemann, Bastian, Berger, Joseph R.
Publicado 2021

Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies

por Berger, Joseph R., Hartung, Hans-Peter
Publicado 2023

Next-generation sequencing of tissue: A logical extension

por Berger, Joseph R., Wilson, Michael R.
Publicado 2016

COVID-19 and MS disease-modifying therapies

por Berger, Joseph R., Brandstadter, Rachel, Bar-Or, Amit
Publicado 2020

Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19

por Shin, Robert K., Repovic, Pavle, Berger, Joseph R.
Publicado 2022

Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event

por Berger, Joseph R., Malik, Vineeta, Lacey, Stuart, Brunetta, Paul, Lehane, Patricia B.
Publicado 2018

Progressive multifocal leukoencephalopathy after fingolimod treatment

por Berger, Joseph R., Cree, Bruce A., Greenberg, Benjamin, Hemmer, Bernhard, Ward, Brian J., Dong, Victor M., Merschhemke, Martin
Publicado 2018

Expression of miR-15/107 Family MicroRNAs in Human Tissues and Cultured Rat Brain Cells

por Wang, Wang-Xia, Danaher, Robert J., Miller, Craig S., Berger, Joseph R., Nubia, Vega G., Wilfred, Bernard S., Neltner, Janna H., Norris, Christopher M., Nelson, Peter T.
Publicado 2014

Cryptococcal Meningitis Reported With Fingolimod Treatment: Case Series

por Del Poeta, Maurizio, Ward, Brian J., Greenberg, Benjamin, Hemmer, Bernhard, Cree, Bruce A.C., Komatireddy, Sreelatha, Mishra, Jitendriya, Sullivan, Roseanne, Kilaru, Ajay, Moore, Alan, Hach, Thomas, Berger, Joseph R.
Publicado 2022

A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials

por Parikh, Asit, Stephens, Kristin, Major, Eugene, Fox, Irving, Milch, Catherine, Sankoh, Serap, Lev, Michael H., Provenzale, James M., Shick, Jesse, Patti, Mark, McAuliffe, Megan, Berger, Joseph R., Clifford, David B.
Publicado 2018

Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR)

por Sabol, Rachel A., Noxon, Virginia, Sartor, Oliver, Berger, Joseph R., Qureshi, Zaina, Raisch, Dennis W., Norris, LeAnn B., Yarnold, Paul R., Georgantopoulos, Peter, Hrushesky, William J., Bobolts, Laura, Ray, Paul, Lebby, Akida, Kane, Robert C., Bennett, Charles L.
Publicado 2017

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis

por Thebault, Simon, Gandelman, Stephanie, Lane, Camryn, Kim, Erin J., Pileggi, Caitlin, Zuroff, Leah, Yamashita, Luana D., Schindler, Matthew K., Chiu, Charles, Wilson, Michael R., Berger, Joseph R., Markowitz, Clyde, Bar-Or, Amit, Fuller, Ryan, Brandstadter, Rachel, Pruitt, Amy A., Jacobs, Dina A.
Publicado 2023

Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases

por Levin, Seth N., Venkatesh, Shruthi, Nelson, Katie E., Li, Yi, Aguerre, Ines, Zhu, Wen, Masown, Karman, Rimmer, Kathryn T., Diaconu, Claudiu I., Onomichi, Kaho B., Leavitt, Victoria M., Levine, Libby L., Strauss‐Farber, Rebecca, Vargas, Wendy S., Banwell, Brenda, Bar‐Or, Amit, Berger, Joseph R., Goodman, Andrew D., Longbrake, Erin E., Oh, Jiwon, Weinstock‐Guttman, Bianca, Thakur, Kiran T., Edwards, Keith R., Riley, Claire S., Xia, Zongqi, De Jager, Philip L.
Publicado 2021